Lactobacillus gasseri BNR17 Supplementation Reduces the Visceral Fat Accumulation and Waist Circumference in Obese Adults: A Randomized, Double-Blind, Placebo-Controlled Trial
Kim J, Yun JM, Kim MK, Kwon O, Cho B
Published in Journal of Medicinal Food, Vol. 21 (5), pp. 454-461
Methodology
Twelve-week randomised double-blind placebo-controlled trial of Lactobacillus gasseri BNR17 in overweight and obese adults measuring body composition
Key Findings
Body weight and BMI did not differ significantly from placebo; only waist and hip circumference showed small reductions in the high-dose group.
Conclusions
L. gasseri BNR17 failed to produce meaningful weight loss in a controlled trial.
Limitations
Twelve weeks may be short; no dietary standardisation.
Supplements Studied
Body weight and BMI did not differ significantly from placebo; only waist and hip circumference showed small reductions in the high-dose group.
Outcomes Measured
Body weight and BMI did not differ significantly from placebo; only waist and hip circumference showed small reductions in the high-dose group.
Related Health Concerns
Study Details
Access Study
This information is for educational purposes only. Always consult a healthcare professional before starting any supplement regimen.